Mitochondria as therapeutic targets in assisted reproduction
Human Reproduction · 01.10.2024 · 39 (10) · 2147-2159
DOI: 10.1093/humrep/deae170 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Reproduction, online erschienen am 27.07.2024. Verfasst von Raziye Melike Yildirim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Mitochondria, Mitochondrial Replacement Therapy, Mitochondrial Diseases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 114 Literaturangaben.
Abstract (Originalsprache)
Mitochondria are essential organelles with specialized functions, which play crucial roles in energy production, calcium homeostasis, and programmed cell death. In oocytes, mitochondrial populations are inherited maternally and are vital for developmental competence. Dysfunction in mitochondrial quality control mechanisms can lead to reproductive failure. Due to their central role in oocyte and embryo development, mitochondria have been investigated as potential diagnostic and therapeutic targets in assisted reproduction. Pharmacological agents that target mitochondrial function and show promise in improving assisted reproduction outcomes include antioxidant coenzyme Q10 and mitoquinone, mammalian target of rapamycin signaling pathway inhibitor rapamycin, and nicotinamide mononucleotide. Mitochondrial replacement therapies (MRTs) offer solutions for infertility and mitochondrial disorders. Autologous germline mitochondrial energy transfer initially showed promise but failed to demonstrate significant benefits in clinical trials. Maternal spindle transfer (MST) and pronuclear transfer hold potential for preventing mitochondrial disease transmission and improving oocyte quality. Clinical trials of MST have shown promising outcomes, but larger studies are needed to confirm safety and efficacy. However, ethical and legislative challenges complicate the widespread implementation of MRTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
ORCID-Profile: Raziye Melike Yildirim, Emre Seli
Zitieren
APA
Yildirim, R. M., & Seli, E. (2024). Mitochondria as therapeutic targets in assisted reproduction. Human Reproduction, 39(10), 2147-2159. https://doi.org/10.1093/humrep/deae170
Vancouver
Yildirim RM, Seli E. Mitochondria as therapeutic targets in assisted reproduction. Human Reproduction. 2024;39(10):2147-2159. doi:10.1093/humrep/deae170
BibTeX
@article{Yildirim2024,
author = {Yildirim, Raziye Melike and Seli, Emre},
title = {Mitochondria as therapeutic targets in assisted reproduction},
journal = {Human Reproduction},
year = {2024},
volume = {39},
number = {10},
pages = {2147--2159},
doi = {10.1093/humrep/deae170}
}
EUVIMED